Related Experiment Video
Updated: Aug 8, 2026

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
p16 proteins from melanoma-prone families are deficient in binding to Cdk4
1Department of Molecular Biology, Massachusetts General Hospital, Boston 02114, USA.
Abstract:
The tumor suppressor candidate p16INK4 is a cyclin-dependent kinase inhibitor that inhibits cell proliferation. The p16 coding gene is often mutated in glioblastomas, pancreatic adenocarcinomas and melanoma-prone pedigrees, but, until recently, the significance of these allelic variants has remained unclear. Here, we used interaction mating and coprecipitation to measure interaction of seven p16 allelic variants detected in melanoma-prone pedigrees with Cyclin-dependent kinases (Cdks). We found that most variants were deficient in interaction with Cdk4 and Cdk6. One defective variant was found both in cancer prone families and in the control population and therefore previously defined as a common polymorphism. Another variant, which is weakly linked to familial cancer, is only slightly affected in interaction with Cdks. These results are consistent with the idea that p16 allelic variants that decrease Cdk interaction predispose individuals who carry them to an increased risk of cancer. Moreover, they suggest that determination of affinity between p16 mutants and partner proteins may help identify functionally-significant allelic variants not detected by classical human genetic techniques.
Insights
The tumor suppressor p16INK4 inhibits cell proliferation. Most p16 variants impair interaction with key cell cycle regulators (Cdks), increasing cancer risk, especially in familial melanoma cases.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- The p16INK4 protein acts as a tumor suppressor by inhibiting cell proliferation.
- Mutations in the p16 gene are frequently observed in glioblastomas, pancreatic adenocarcinomas, and melanoma-prone families.
- The functional impact of many p16 allelic variants has remained largely undetermined.
Purpose of the Study:
- To investigate the interaction between seven p16 allelic variants found in melanoma-prone pedigrees and Cyclin-dependent kinases (Cdks).
- To determine if impaired Cdk interaction by p16 variants correlates with cancer predisposition.
Main Methods:
- Interaction mating assays were employed to assess protein-protein interactions.
- Coprecipitation techniques were utilized to measure the binding affinity between p16 variants and Cdks.
- Analysis included seven p16 allelic variants detected in individuals with a history of melanoma.
Main Results:
- Most tested p16 allelic variants demonstrated reduced interaction with Cdk4 and Cdk6.
- One variant, previously considered a common polymorphism, showed defective Cdk interaction.
- A variant weakly associated with familial cancer exhibited only a minor decrease in Cdk binding affinity.
Conclusions:
- p16INK4 allelic variants that exhibit decreased binding to Cdks are associated with an increased risk of cancer.
- Assessing the binding affinity of p16 mutants to partner proteins can identify functionally significant variants.
- This approach may reveal functionally important p16 variants missed by traditional genetic studies.
More Related Videos
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Positive Regulator Molecules
Inhibition of Cdk Activity
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Abnormal Proliferation

